METIS TECHBIO-P (07666) has officially been included in the Stock Connect, opening up a channel for mainland investors to participate.

On September 4th, the Shanghai Stock Exchange issued a notice stating that according to the relevant provisions of the "Shanghai Stock Exchange Stock Connect Implementation Rules," METIS TECHBIO-P (07666) has officially been added to the list of stocks eligible for the Hong Kong Stock Connect. This adjustment will take effect on September 7th (Monday). This means that mainland investors can now directly trade JiTai Technology through the Shanghai-Shenzhen-Hong Kong Stock Connect, officially unlocking southbound capital. In the first half of this year, JiTai Technology achieved operating income of 154 million yuan, a substantial year-on-year increase of 13,339%, exceeding last year's total income by 47%. During the reporting period, JiTai Technology also realized the external industrial infrastructure-level application of NanoForge, promoting the company's AiTEM artificial intelligence formulation innovation platform to reach cooperation with Jiangsu Hengrui Pharmaceuticals; and signed an exclusive licensing agreement with BioThunder AG, obtaining 15 million yuan in exclusive licensing fees, covering up to 10 candidate products; and signed a strategic cooperation agreement with Apeloa Pharmaceutical to jointly build an "AI+CDMO" pharmaceutical innovation ecosystem.